Zai Lab Limited Unsponsored ADR ZLAB

24.98 (0.30) (1.19%) as of 25 Sep
Market cap
$2.9B
P/E
0.0×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

(28.97%) (22.56%) (24.19%) (26.91%)
ROA
(19.29%) (14.89%) (15.70%) (16.81%)
ROIC
(97.69%) (109.92%) (132.39%) (129.34%)
Return on Tangible Assets
(28.64%) (26.98%) (29.74%) (35.39%)
Average Days of Receivables
70.56 84.17 43.54 56.50
Free Cash Flow per Share
(1.91) (1.50) (1.20) (1.45)
Free Cash Flow
(210.33) (164.13) (132.76) (162.43)
Capital Expenditures
(29.79) (13.34) (31.76) (29.05)
Piotroski F-Score
3.00 3.00 3.00 3.00
Other line items
Cash ROIC
(10.14%) (8.82%) (6.17%) (8.54%)
Accounts Receivable Turnover
6.53 4.81 6.94 5.69
Accounts Payable Turnover
1.55 1.58 1.66 1.60
Inventory Turnover
3.20 3.33 2.74 2.57
Average Days of Payables
213.02 270.50 241.40 254.93
Days of Inventory on Hand
143.43 142.78 164.47 169.51
Tax Rate
0.00 0.00 0.00 0.00
Research and Development Expense of Revenue
47.90% 48.01% 49.81% 52.69%
Selling, General and Administrative Expense of Revenue
65.03% 60.33% 61.61% 62.52%
Share Based Compensation of Revenue
15.16% 14.26% 13.97% 12.96%
Interest Coverage
0.00 0.00 0.00 0.00
Operating CF/Net income
0.87 0.86 0.57 0.71
Depreciation/Fixed assets
0.19 0.20 0.21 0.22
Capex/Depreciation
(3.26) (1.38) (3.15) (2.79)
Revenue per Share
4.01 4.20 4.09 4.03
Operating CF per Share
(1.64) (1.38) (0.91) (1.19)
Capex per Share
(0.27) (0.12) (0.29) (0.26)
Capex to Sales
0.07 0.03 0.07 0.06
Net Profit Margin
(46.83%) (38.15%) (39.29%) (41.86%)

Fold the line items

Columns are period end dates